Variant report
Variant | nsv969750 |
---|---|
Chromosome Location | chr9:13374271-13378180 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr9:13370327..13372389-chr9:13372731..13374721,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs532762042 | chr9:13375861-13375862 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs552758125 | chr9:13375903-13375904 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs568983558 | chr9:13375945-13375946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs532244585 | chr9:13375956-13375957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs187642892 | chr9:13375974-13375975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs548255888 | chr9:13376032-13376033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs568028152 | chr9:13376085-13376086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs533878925 | chr9:13376104-13376105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs73410156 | chr9:13376159-13376160 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs370502135 | chr9:13376190-13376191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs539255345 | chr9:13376244-13376245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs549042933 | chr9:13376277-13376278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs575378363 | chr9:13376301-13376302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs550423391 | chr9:13376304-13376305 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs544276621 | chr9:13376317-13376318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs141980001 | chr9:13376324-13376325 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs373708526 | chr9:13376338-13376339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs150097585 | chr9:13376360-13376361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs73410157 | chr9:13376374-13376375 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs138445946 | chr9:13376464-13376465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs577426163 | chr9:13376523-13376524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs189828917 | chr9:13376558-13376559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs540332703 | chr9:13376587-13376588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs149284419 | chr9:13376607-13376608 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs73410158 | chr9:13376628-13376629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs144315080 | chr9:13376652-13376653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs566929187 | chr9:13376673-13376674 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs561596165 | chr9:13376694-13376695 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs527306867 | chr9:13376710-13376711 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs547035056 | chr9:13376728-13376729 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs181605065 | chr9:13376793-13376794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs530780773 | chr9:13376802-13376803 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs373115968 | chr9:13376807-13376808 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs148353452 | chr9:13376830-13376831 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs185590567 | chr9:13376907-13376908 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs549591582 | chr9:13376939-13376940 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs73410159 | chr9:13376941-13376942 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs142212839 | chr9:13376943-13376944 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs555066593 | chr9:13376960-13376961 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs146400184 | chr9:13377001-13377002 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs190311368 | chr9:13377002-13377003 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs553871304 | chr9:13377022-13377023 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs577660170 | chr9:13377031-13377032 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs559094512 | chr9:13377041-13377042 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs370164323 | chr9:13377042-13377043 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs566477547 | chr9:13377044-13377045 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs563111219 | chr9:13377045-13377046 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs182803815 | chr9:13377063-13377064 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs139774960 | chr9:13377065-13377066 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs528285405 | chr9:13377069-13377070 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21611746 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:13375800-13376400 | Enhancers | Placenta Amnion | Placenta Amnion |
2 | chr9:13376400-13377400 | Weak transcription | Placenta Amnion | Placenta Amnion |
3 | chr9:13376800-13378600 | Enhancers | Muscle Satellite Cultured Cells | -- |
4 | chr9:13376800-13378800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
5 | chr9:13377000-13377800 | Enhancers | Osteobl | bone |
6 | chr9:13377200-13377600 | Enhancers | HUVEC | blood vessel |
7 | chr9:13377200-13378800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr9:13377200-13378800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
9 | chr9:13377200-13378800 | Enhancers | HSMM | muscle |
10 | chr9:13377200-13378800 | Enhancers | HSMMtube | muscle |
11 | chr9:13377400-13377800 | Enhancers | Ovary | ovary |
12 | chr9:13377400-13377800 | Enhancers | NH-A | brain |
13 | chr9:13377400-13378600 | Enhancers | Colon Smooth Muscle | Colon |
14 | chr9:13377600-13377800 | Enhancers | Placenta Amnion | Placenta Amnion |
15 | chr9:13377600-13383000 | Weak transcription | HUVEC | blood vessel |
16 | chr9:13377800-13378000 | Enhancers | NHDF-Ad | bronchial |
17 | chr9:13377800-13378600 | Weak transcription | Osteobl | bone |
18 | chr9:13377800-13378800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |